Address: Of. 218, bld. 2, 11a, Seleznevskaya str., Moscow 127473,Russia
Tel: (495) 741-65-19
The Union of Professional Pharmaceutical Organizations (SPFO) was registered in May 2002, to unite the largest Russian and foreign distributors and pharmaceutical manufacturers, which account for more than 50% of the total volume of drugs circulating in the market .
At this point in the SPFO includes 36 organizations : manufacturers, distributors, drugstore chains, public organizations and companies representing the media.
The supreme governing body SPFO a general meeting. Current work SPFO directs the Supervisory Board of 14 members. Chairman of the Supervisory Board is Yakunin, VS (CV Protek). Executive Director of the Union is a seasoned professional pharmaceutical organizations Shirshov GP
SPFO activities organized on the principle of specific programs and projects. Basic principles of decision making in SPFO – collegiality and democracy.
The main objectives of SPFO are:
•promote the development of the pharmaceutical market in Russia;
•opposition to unethical business practices in the pharmaceutical industry;
•assist in balancing the interests of the pharmaceutical market participants, government and consumers;
•development and expansion of the capacity of members SPFO.
•protection of consumer interests in terms of quality and affordability of drugs;
•support structures of the government in addressing the strategic development objectives of pharmaceutical market;
•Members SPFO coordination in joint projects;
•Providing a forum for free communication between members of the pharmaceutical market;
•upholding the rights and legitimate interests of the members SPFO;
•cooperation with the legislative and executive authorities, public, nonprofit and international organizations;
•popularization of progressive experience of SPFO and its members.
Currently SPFO the following programs and projects:
•Harmonization of legislation;
•Assistance in establishing a system of drug reimbursement in the Russia;
•Promotion of international quality standards in the pharmaceutical industry (GMP / GXP);
•Assist in improving the system of public procurement of medicines;
•Forming the system of scientific-practical conferences on topical issues of the pharmaceutical industry;
•The program ‘A Place Pharmacy in a single economic space’;
•Organizing and conducting an annual ‘International Forum / Exhibition / Fair on’ Innovative Technologies for Health ‘;
•The organization’s annual charity ball dispensers;
•Edition of the journal ‘Health management’.
Many expat managers have used Russia as a stepping-stone, but you have headed this business for an astounding 9…
IMEDA was founded in 2005, and today counts amongst its members 28 leading international companies in the Russian…
When we first met, you mentioned that you assumed this position in 2009, to help UCB Russia recover from a flat…
Merck KGaA describes itself as the world’s oldest pharmaceutical and chemicals company. What is the…
Ipsen has recently announced the acquisition of a Russian pharmaceutical license. Even before this license, Russia…
What were the difficulties in the CIS regions around the time of the financial crisis? Were there similarities to…
You have been with Boehringer Ingelheim since the early days of your career in 1994. In the pharmaceutical sector,…
You were the former director of RMBC, which was acquired in 2008 by the IMS. How important was this acquisition in…
Roche is the leading company in the ONLS (high-technology reimbursement) segment of the prescription drug market,…
You have been in Russia now for a bit less than a year, having come from the former Schering-Plough’s Hungary…
Binnopharm was established in 2006, with 100% of charter capital coming from holding company JSFC Sistema. What was…